Dental pulp-derived stem cell conditioned medium reduces cardiac injury following ischemia-reperfusion

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Yamaguchi, Satoshi ^a   Shibata, Rei ^a   Yamamoto, Noriyuki ^a   Nishikawa, Masaya ^a   Hibi, Hideharu ^a   Tanigawa, Tohru ^b   Ueda, Minoru ^a   Murohara, Toyoaki ^a   Yamamoto, Akihito ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONDITIONED MEDIUM;

ANIMAL; APOPTOSIS; CONDITIONED MEDIUM; CYTOLOGY; HEART INFARCTION; MOUSE; PATHOLOGY; REPERFUSION INJURY; STEM CELL; TOOTH PULP;

ANIMALS; APOPTOSIS; CULTURE MEDIA, CONDITIONED; DENTAL PULP; MICE; MYOCARDIAL INFARCTION; REPERFUSION INJURY; STEM CELLS;

EID: 84946771830     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16295     Document Type: Article

References (27)

1. Eisenberg, M. S., Mengert, T. J. Cardiac resuscitation. N. Engl. J. Med. 344, 1304-1313 (2001).
2. Verma, S. et al. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 105, 2332-2336 (2002).
3. Passier, R., van Laake, L. W., Mummery, C. L. Stem-cell-based therapy and lessons from the heart. Nature 453, 322-329 (2008).
4. Gronthos, S., Mankani, M., Brahim, J., Robey, P. G., Shi, S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 97, 13625-13630 (2000).
5. Miura, M. et al. SHED: stem cells from human exfoliated deciduous teeth. Proc. Natl. Acad. Sci. USA. 100, 5807-5812 (2003).
6. Sakai, K. et al. Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms. J. Clin. Invest. 122, 80-90 (2012).
7. Matsubara, K. et al. Secreted ectodomain of sialic acid-binding Ig-like lectin-9 and monocyte chemoattractant protein-1 promote recovery after rat spinal cord injury by altering macrophage polarity. J. Neurosci. 35, 2452-2464 (2015).
8. Inoue, T. et al. Stem cells from human exfoliated deciduous tooth-derived conditioned medium enhance recovery of focal cerebral ischemia in rats. Tissue Eng Part A 19, 24-29 (2013).
9. Yamagata, M. et al. Human dental pulp-derived stem cells protect against hypoxic-ischemic brain injury in neonatal mice. Stroke 44, 551-554 (2013).
10. Gandia, C. et al. Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction. Stem Cells 26, 638-645 (2008).
11. Pittenger, M. F., Martin, B. J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95, 9-20 (2004).
12. Zhang, M. et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J. Mol. Cell. Cardiol. 33, 907-921 (2001).
13. Ranganath, S. H., Levy, O., Inamdar, M. S., Karp, J. M. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10, 244-258 (2012).
14. Pawitan, J. A. Prospect of stem cell conditioned medium in regenerative medicine. Biomed Res Int 2014, 965849 (2014).
15. Timmers, L. et al. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res 6, 206-214 (2011).
16. Yang, D. et al. The relative contribution of paracine effect versus direct differentiation on adipose-derived stem cell transplantation mediated cardiac repair. PLoS One 8, e59020 (2013).
17. Yamamoto, A., Sakai, K., Matsubara, K., Kano, F., Ueda, M. Multifaceted neuro-regenerative activities of human dental pulp stem cells for functional recovery after spinal cord injury. Neurosci. Res. 78, 16-20 (2014).
18. MacLellan, W. R., Schneider, M. D. Death by design. Programmed cell death in cardiovascular biology and disease. Circ. Res. 81, 137-144 (1997).
19. Frangogiannis, N. G., Smith, C. W., Entman, M. L. The inflammatory response in myocardial infarction. Cardiovasc. Res. 53, 31-47 (2002).
20. Kitta, K. et al. Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells. J. Biol. Chem. 278, 4705-4712 (2003).
21. Morishita, R., Aoki, M., Yo, Y., Ogihara, T. Hepatocyte growth factor as cardiovascular hormone: role of HGF in the pathogenesis of cardiovascular disease. Endocr. J. 49, 273-284 (2002).
22. Grzelakowska-Sztabert, B., Dudkowska, M. Paradoxical action of growth factors: antiproliferative and proapoptotic signaling by HGF/c-MET. Growth Factors 29, 105-118 (2011).
23. Nakagami, H. et al. Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation from cytosol to mitochondrial membrane. Diabetes 51, 2604-2611 (2002).
24. Nakamura, T. et al. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J. Clin. Invest. 106, 1511-1519 (2000).
25. Shibata, R. et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK-and COX-2-dependent mechanisms. Nat. Med. 11, 1096-1103 (2005).
26. Kataoka, Y. et al. Omentin prevents myocardial ischemic injury through AMPK-and Akt-dependent mechanisms. J. Am. Coll. Cardiol. 63, 2722-2233 (2014).
27. Ogura, Y. et al. Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models. Circulation 126, 1728-1738 (2012).